Michael E. Severino

Vice Chairman & President at AbbVie, Inc.

Michael E. Severino

Michael E. Severino

Vice Chairman & President at AbbVie, Inc.

Overview
Career Highlights

AbbVie, Inc.

RelSci Relationships

6574

Number of Boards

5

Birthday

1966

Age

54

Contact Data
Trying to get in touch with Michael E. Severino? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Michael E. Severino likely has professional access to. A relationship does not necessarily indicate a personal connection.

Through Ownership/Position at Front Barnett Associates LLC

Relationship likelihood: Strong

Vice Chair, Finance at The Field Museum of Natural History

Relationship likelihood: Strong

President & Chief Executive Officer at The Field Museum of Natural History

Relationship likelihood: Strong

President & Chief Executive Officer at Tobira Therapeutics, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at AbbVie, Inc.

Relationship likelihood: Strong

Vice Chairman, External Affairs & Chief Legal Officer at AbbVie, Inc.

Relationship likelihood: Strong

Chief Executive Officer at AbbVie, Inc.

Relationship likelihood: Strong

Chief of Staff & Director-CCF at The Cleveland Clinic Foundation Group Return

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at Syngenta AG

Relationship likelihood: Strong

Advisor at Ember Technologies, Inc.

Relationship likelihood: Strong

Paths to Michael E. Severino
Potential Connections via
Relationship Science
You
Michael E. Severino
Vice Chairman & President at AbbVie, Inc.
Career History
Vice Chairman & President
2014 - Current

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on 2013 and is headquartered in North Chicago, IL.

Chief Medical Officer & Senior Vice President, Global Development
2004 - 2014

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Associate Director/Director/Senior Director
1998 - 2004

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Boards & Committees
Senior Director
Prior
Transactions
Details Hidden

AbbVie, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michael E. Severino. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michael E. Severino's profile does not indicate a business or promotional relationship of any kind between RelSci and Michael E. Severino.